Pfizer and BioNTech have submitted a request for European Union drug regulators to increase the approval of the businesses’ coronavirus vaccine to incorporate youngsters ages 12 to fifteen, a transfer that might supply youthful and fewer at-risk populations in Europe entry to the pictures for the primary time.
In an announcement on Friday, the 2 corporations stated their submission to the European Medicines Company was primarily based on a sophisticated research in additional than 2,000 adolescents that confirmed the vaccine to be secure and efficient. The youngsters will proceed to be monitored for longer-term safety and security for an additional two years.
BioNTech CEO says he expects Europe to achieve herd immunity this summer time
BioNTech and Pfizer beforehand had requested their emergency use authorization with the U.S. Meals and Drug Administration even be prolonged to youngsters 12-15.
The COVID-19 vaccine made by Pfizer and BioNTech was the primary one to be granted a greenlight by the EMA in December, when it was licensed for anybody age 16 and over throughout the 27-nation EU.
View hyperlink »
© 2021 The Canadian Press